NewsRx

Search our medical news database

Vaccine Development (TB)

Recombinant M. vaccae Useful in Search for TB Vaccine

Published in TB and Outbreaks Week, May 19th, 1997

The recombinant Mycobacterium vaccae system may be a useful tool in the search for tuberculosis vaccine candidates.

Researcher Christiane Abou-Zeid and colleagues found that the M. vaccae system is a convenient approach to the induction of type 1 responses to M. tuberculosis antigens.

T-cell-mediated immune responses can be categorized broadly as type I or II, based on the predominant cytokine profile expressed by the activated lymphocytes. A type I response is dominated by the production of gamma interferon (IFN-gamma), which triggers activation of macrophages, enhancing their microbicidal functions. A type II response is...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook